Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2025-12-24 @ 12:43 PM
NCT ID:
NCT01198561
Eligibility Criteria:
Inclusion Criteria:
* Twenty patients fulfilling the diagnostic criteria of major depression according to DSM IV will be enrolled in the study.
* Antidepressant medication will be maintained throughout the study period.
Exclusion Criteria:
* Exclusion criteria are current neurological or other psychiatric disorders, as well as a history of epileptic seizures, substantial brain damage or neurosurgical operation, according to established safety criteria.
* To exclude the effect of drug changes on post-rTMS cerebral glucose metabolism, the combinations and dosage of pre-rTMS antidepressant drugs will remain unchanged until the post-rTMS 18FDG PET is done.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01198561
Study Brief:
Protocol Section:
NCT01198561